These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20636529)

  • 1. Progress in monitoring blood safety.
    Epstein JS; Holmberg JA
    Transfusion; 2010 Jul; 50(7):1408-12. PubMed ID: 20636529
    [No Abstract]   [Full Text] [Related]  

  • 2. [Transfusion safety].
    Aprili G
    Haematologica; 1991 Jun; 76 Suppl 3():385-94. PubMed ID: 1752537
    [No Abstract]   [Full Text] [Related]  

  • 3. The cost-effectiveness of introducing nucleic acid testing to test for hepatitis B, hepatitis C, and human immunodeficiency virus among blood donors in Sweden.
    Davidson T; Ekermo B; Gaines H; Lesko B; Åkerlind B
    Transfusion; 2011 Feb; 51(2):421-9. PubMed ID: 20849409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing)].
    Pillonel J; Laperche S; ; ;
    Transfus Clin Biol; 2004 Apr; 11(2):81-6. PubMed ID: 15120104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors].
    Contreras AM; Reta CB; Torres O; Celis A; Domínguez J
    Salud Publica Mex; 2011; 53 Suppl 1():S13-8. PubMed ID: 21877067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran: An Eleven-Year Retrospective Study.
    Farshadpour F; Taherkhani R; Tajbakhsh S; Gholizadeh Tangestani M; Hajiani G; Sharifi N; Taherkhani S; Nejadbolkheyr A
    PLoS One; 2016; 11(6):e0157615. PubMed ID: 27309959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Viral safety of blood and blood products].
    Gürtler L
    Fortschr Med; 1993 Nov; 111(33):526-7. PubMed ID: 8307536
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
    Kafi-abad SA; Rezvan H; Abolghasemi H; Talebian A
    Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evading bad blood.
    S Afr Med J; 1996 Apr; 86(4):315-6, 317. PubMed ID: 8693359
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of Hepatitis C Virus and Hepatitis B Virus Infections in Patients Infected with HIV Through Blood Donation or Transfusion in China.
    Zeng QL; Yu ZJ
    AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1203. PubMed ID: 26160448
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of transfusion transmitted infections in blood donors: an Indian experience.
    Chandra T; Kumar A; Gupta A
    Trop Doct; 2009 Jul; 39(3):152-4. PubMed ID: 19535750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
    Singh B; Verma M; Verma K
    Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety of blood components and derivatives.
    Julius C; Westphal RG
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1057-77. PubMed ID: 1400072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion-transmitted hepatitis virus infection.
    Dodd RY
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):137-54. PubMed ID: 7737938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative safety of first-time volunteer and replacement donors in West Africa.
    Allain JP; Sarkodie F; Asenso-Mensah K; Owusu-Ofori S
    Transfusion; 2010 Feb; 50(2):340-3. PubMed ID: 19843284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of the Ministry of Health in the prevention of diseases caused by blood transfusion].
    Wolpert Barraza E; Córdova MS; Robles Díaz G; Reyes López PA
    Gac Med Mex; 1994; 130(6):412-24. PubMed ID: 7557054
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serological monitoring of natural focal infections in blood donors].
    Nafeev AA; Khapman ME; Avdeeva GA
    Klin Lab Diagn; 2006 Dec; (12):34-5. PubMed ID: 17315675
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century.
    Dwyre DM; Fernando LP; Holland PV
    Vox Sang; 2011 Jan; 100(1):92-8. PubMed ID: 21175659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evolution of residual risk for HIV, HCV and HBV, from 1999 to 2010, in blood donations of the Centro Hospitalar S. João, EPE, Porto, Portugal].
    Koch C; Araújo F
    Acta Med Port; 2013; 26(4):371-6. PubMed ID: 24016646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.